{
  "main_header": {
    "sid": 1002833,
    "name": "Dishman Carbogen",
    "stock_name": "Dishman Carbogen",
    "full_name": "Dishman Carbogen Amcis Ltd",
    "name_url": "stocks-analysis/dishman-carbogen",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "193.35",
    "chg": 5.2,
    "chgp": "2.76%",
    "dir": 1,
    "prev_price": "188.15",
    "mcapval": "2,985.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 540701,
    "symbol": "DCAL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE385W01011",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "90.86 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/dishman-carbogen-1002833-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dishman Carbogen Amcis Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-4002203",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DishmanCarbogen_technicaldot_4002203.png",
        "date": "2026-05-21 08:04:03",
        "description": "Dishman Carbogen Amcis Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum, reflected in a 12.01% surge in its share price on 21 May 2026. Despite this intraday strength, technical indicators present a complex picture with mixed signals across weekly and monthly timeframes, prompting a reassessment of the stock’s near-term outlook."
      },
      {
        "title": "Dishman Carbogen Amcis Ltd Surges 7.74% to Day's High of Rs 203.9 — Outperforms Sector by 6.73 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dishman-carbogen-amcis-ltd-hits-intraday-high-with-774-surge-on-20-may-2026-4000533",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DishmanCarbogen_priceRelatedfactors_4000533.png",
        "date": "2026-05-20 09:46:12",
        "description": "The Sensex declined by 0.48% on 20 May 2026, while Dishman Carbogen Amcis Ltd surged 7.74%, marking a remarkable 6.73-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the stock, which has been on a two-day winning streak."
      }
    ],
    "total": 15,
    "sid": "1002833",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/dishman-carbogen-amcis-1002833"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Considering And Approving The Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures By Way Of Private Placement Subject To Such Regulatory Or Statutory Approvals As May Be Required",
      "datetime": "07-Aug-2026",
      "details": "Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve the Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures By Way Of Private Placement Subject To Such Regulatory Or Statutory Approvals As May Be Required",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Jul-2026",
      "details": "Pls. find enclosed herewith Newspaper Advertisement published on 17th July 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Jul-2026",
      "details": "Please find enclosed herewith Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th June 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dishman Carbogen Amcis Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 19",
          "dt": "2019-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dishman Carbogen Amcis Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-05-21 08:04:03

Dishman Carbogen Amcis Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum, reflected in a 12.01% surge in its share price on 21 May 2026. Despite this intraday strength, technical indicators present a complex picture with mixed signals across weekly and monthly timeframes, prompting a reassessment of the stock’s near-term outlook.

Read More

Dishman Carbogen Amcis Ltd Surges 7.74% to Day's High of Rs 203.9 — Outperforms Sector by 6.73 Percentage Points

2026-05-20 09:46:12

The Sensex declined by 0.48% on 20 May 2026, while Dishman Carbogen Amcis Ltd surged 7.74%, marking a remarkable 6.73-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the stock, which has been on a two-day winning streak.

Read More

View All News